CO-NEWMONT
1.6.2020 15:02:10 CEST | Business Wire | Press release
Newmont Corporation (NYSE: NEM, TSX: NGT) (Newmont or The Company) today announced the publication of its 2019 Sustainability Report, Beyond the Mine , a transparent and comprehensive disclosure of the Company’s environmental, social and governance (ESG) performance.
“Our sustainability report provides investors and other stakeholders a transparent and detailed look at look at our safety, environmental and social performance,” said Tom Palmer, President and Chief Executive Officer. “In 2019, we completed two transformative transactions whilst enhancing our ESG performance to align with our position as the world’s leading gold company.”
Newmont’s 2019 sustainability highlights include:
- Achieving no workplace fatalities and conducting a global safety culture review, which identified several opportunities to enhance Newmont’s Fatality Risk Management program and improve the way fatality risks are managed
- Further strengthening management of tailings, whilst enhancing transparency through a new tailings website with details on all 104 tailings dam facilities at Newmont’s operating sites, joint ventures, subsidiaries and legacy sites
- Reducing greenhouse gas emissions intensity by 13.7 percent, compared to the 2013 baseline, which achieves approximately 83 percent of Newmont’s target to reduce GHG emissions intensity by 16.5 percent by the end of 2020
- Engaging with government, community and contractors to resolve a dispute at the Peñasquito operation in Mexico, which resulted in reaching a 30-year water agreement with the San Juan de Cedros community and signing a memorandum of understanding for an Investment and Social Development Plan that details Newmont’s commitments to the community
- Creating the Global Center for Indigenous Community Relations and the Advisory Council of Canadian and Indigenous Affairs to further enhance Newmont’s global approach to indigenous relations and ensure all commitments to First Nations in Canada and elsewhere are honored
The report also includes an update on Newmont’s efforts – such as protective measures at operating sites and the establishment of a $20 million fund to support communities – to help manage the impacts of the COVID-19 pandemic.
Newmont’s sustainability efforts have been recognized by several independent organizations:
- For the fifth year in a row, Newmont was named the top gold miner in the Dow Jones Sustainability World Index (DJSI)
- Newmont earned a “B” score from CDP for its 2019 Climate Change and Water Security performance
- Newmont was added to the Corporate Human Rights Benchmark’s (CHRB) 2019 evaluation and was ranked 12 th out of more than 200 companies that were assessed against the CHRB’s human rights performance criteria
- For the second consecutive year, Newmont was included in Bloomberg’s Gender-Equality Index (GEI) for its efforts to advance qualified women in the workplace
- Newmont was the top mining company in CR Magazine ’s 100 Best Corporate Citizens list and FORTUNE’s 2020 list of the World’s Most Admired Companies
- Newsweek included Newmont on its first-ever list of America’s Most Responsible Companies for 2020
To meet the needs of both investors and a broader range of stakeholders, Newmont’s 2019 Sustainability Report was written in accordance with the GRI (formerly Global Reporting Initiative) Standards Core option, including the GRI Mining and Metals Sector Supplement, and it follows the Sustainability Accounting Standards Board (SASB) Metals & Mining Sustainability Accounting Standard, the framework preferred by investors. In addition, the report’s climate change information aligns with the Task Force on Climate-related Financial Disclosures (TCFD) reporting guidelines.
Issues and metrics covered in Beyond the Mine were selected based on comprehensive engagement with Newmont employees and leadership; a specially convened panel of global opinion leaders from NGOs, academia and the investor community; and hands-on engagement and reviews with the Safety and Sustainability Committee of Newmont’s Board of Directors.
The report demonstrates Newmont’s commitment to disclosing its performance – including site-level data – on its most material sustainability topics. The full report, along with ESG data tables and a comprehensive GRI/SASB/TCFD content index, is available as a downloadable document on Newmont’s website .
About Newmont
Newmont is the world’s leading gold company and a producer of copper, silver, zinc and lead. The Company’s world-class portfolio of assets, prospects and talent is anchored in favorable mining jurisdictions in North America, South America, Australia and Africa. Newmont is the only gold producer listed in the S&P 500 Index and is widely recognized for its principled environmental, social and governance practices. The Company is an industry leader in value creation, supported by robust safety standards, superior execution and technical proficiency. Newmont was founded in 1921 and has been publicly traded since 1925.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200601005244/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
